Tarsons Products Share Price

Tarsons Products Limited is an Indian company engaged in the manufacturing and marketing of plastic laboratory consumables and reusable labware. It operates within the life sciences and scientific instruments sector, supplying products used in research, diagnostics, and pharmaceutical applications. The company designs, develops, and manufactures a wide range of plastic labware, including centrifuge ware, cryo labware, cell culture products, liquid handling systems, genomics and Polymerase Chain Reaction (PCR) consumables, and benchtop laboratory equipment.

Tarsons Products Limited has manufacturing facilities located in West Bengal and maintains a distribution network across India. It also exports its products to multiple international markets. The company serves a variety of institutional customers such as research laboratories, pharmaceutical companies, diagnostic centres, and academic institutions. Its product portfolio includes both consumables and reusable labware, supporting routine laboratory processes and specialised scientific work.

Tarsons Products share price is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Tarsons Products stock price movements have shown sensitivity to spending patterns in the pharmaceutical and research sectors. Tarsons Products share trend has remained linked to domestic laboratory demand, while Tarsons Products share price 2025-2026 has experienced a correction phase following margin pressures during FY 2024-25. Investors tracking Tarsons Products stock price live and Tarsons Products share price today have observed fluctuations associated with earnings performance and sector-related spending cycles.

Tarsons Products Limited Company Fundamentals

(A) Company Background

Tarsons Products Limited history traces to its incorporation on 5th July 1983 in Kolkata, West Bengal. The company was established by the Sehgal family as a domestic manufacturer of plastic labware to serve India’s growing scientific and research community.

Tarsons Products Limited headquarters is located at Salt Lake, Sector V, Kolkata, West Bengal. Over four decades, the company has evolved into a leading Indian manufacturer and supplier of plastic labware for the life sciences industry.

Through successive manufacturing capacity additions and new product introductions, Tarsons Products Limited has expanded its portfolio to over 1,700 SKUs across 300 products.

Tarsons Products Limited was listed on the stock exchanges in November 2021 following its Initial Public Offering (IPO).

(B) Company Product Lines

Tarsons Products Limited product portfolio is structured around three primary labware categories:

Consumables:
Includes pipette tips, petri dishes, centrifuge tubes, cryo labware, PCR consumables, liquid handling products, and related items. This segment represents high-volume, repeat-use products required for routine laboratory operations.

Reusables:
Includes bottles, carboys, measuring cylinders, racks, and other laboratory containers designed for repeated use. These products are typically autoclavable and cater to research institutions, pharmaceutical manufacturers, and diagnostic laboratories.

Others – Benchtop Equipment and Instruments:
Includes vortex mixers, centrifuges, pipettors, and related laboratory equipment supporting scientific workflows.

Tarsons Products Limited operates a vertically integrated value chain covering product design, mould development, injection moulding, assembly, quality control, and distribution.

Its customer base spans pharmaceutical companies, Contract Research Organisations (CROs), diagnostic laboratories, academic institutions, and hospitals across domestic and international markets.

(C) Company Revenue Model

Tarsons Products Limited derives revenue primarily from the manufacturing and sale of plastic labware products. The company operates through:

• A pan-India distributor and dealer network
• Direct institutional sales to large customers
• Export sales to international markets

The business model is anchored in domestic manufacturing with a focus on import substitution in the Indian labware market.

Revenue mix is predominantly B2B, serving research, pharmaceutical, and healthcare sectors, with exports contributing a meaningful share of total revenue.

(D) Geographic Presence

Tarsons Products Limited geographic presence includes:

Headquarters / Registered Office:
Salt Lake, Kolkata, West Bengal

Manufacturing Facilities:
Multiple facilities located in West Bengal, including key sites at Jangalpur, Panchla, Dhulagarh, Amta, and other locations.

India Footprint:
Pan-India distribution network supported by a large base of authorised distributors.

International Presence:
Exports to over 40 countries across Europe, Americas, Middle East, and Asia through global distributor partnerships.

Subsidiary:
Tarsons Life Sciences Pte. Ltd., Singapore (established to support international expansion).

(E) Leadership

Key leaders as of March 2026

• Santosh Kumar Agarwal – Company Secretary / Compliance Officer / Chief Financial Officer
• Lakshmananarayanan Balakrishna Reddy – Vice President (Operations)
• Subhra Sankar Bose – Head (Human Resources)
• Sanjive Sehgal – Chairman / Executive Director / Managing Director / Promoter
• Aryan Sehgal – Whole-time Director
• Viresh Oberai – Independent Non-Executive Director
• Suresh Eshwara Prabhala – Non-Executive & Non-Independent Director
• Divya Momaya – Independent Non-Executive Director
• Monjori Mitra – Independent Non-Executive Director
• Ramanathan Subramanian Arun Kumar – Independent Non-Executive Director
• Vinesh Kriplani – Additional Director

(F) Key Milestones

• 1983: Incorporation of Tarsons Products Limited on 5th July 1983 in Kolkata, West Bengal.
• 2000s: Expansion of manufacturing footprint in West Bengal and significant scaling of product portfolio.
• 2021: Initial Public Offering (IPO) and listing on BSE and NSE in November 2021.
• 2022 onwards: Expansion of manufacturing capacity, including facilities at Panchla and Amta.
• Recent Years: Strengthening of global distribution network and establishment of international presence through overseas subsidiary and exports to 40+ countries

(G) Industry Perspective

India’s laboratory consumables and scientific instruments industry has historically operated through demand cycles shaped by pharmaceutical Research and Development (R&D) spending, government research institution budgets, and diagnostic laboratory infrastructure investment. The global labware market has been driven by biologics manufacturing growth, genomics research expansion, and rising clinical diagnostic testing volumes. India’s push toward domestic manufacturing of scientific consumables – historically dominated by imported products from Germany, the United States, and China – has created significant structural opportunity for domestic labware manufacturers through FY 2024-25. The government’s Production Linked Incentive (PLI) scheme for medical devices and the growth of Indian pharmaceutical contract manufacturing have further accelerated domestic laboratory consumables demand.

Tarsons Products operates at the core of India’s import substitution opportunity in scientific labware as of FY 2024-25. Tarsons Products share price has reflected the structural demand tailwinds from India’s growing pharmaceutical and research sectors. Rising global interest in India as a research and manufacturing destination has continued to expand the addressable market. Tarsons Products stock price has implied investor assessment of its positioning within India’s growing laboratory consumables ecosystem through FY 2024-25.

Tarsons Products Limited Stock Market Presence – Listing And Index Representation

Tarsons Products has its equity shares listed on BSE under the scrip code 543399 and on the National Stock Exchange (NSE) under the symbol TARSONS. Its International Securities Identification Number (ISIN) is INE835Z01014. The company was listed on both exchanges on 24th November 2021 after its mainboard IPO.

Tarsons Products is classified as a small-cap company. As of FY 2024-25, it is not part of major benchmark indices such as the Nifty 50 or Sensex. However, it is associated with broader market indices including S&P BSE Healthcare, BSE 1000, BSE Next 250 Microcap, S&P BSE MidSmallCap, S&P BSE SmallCap, and S&P BSE AllCap.

Tarsons Products share price reflects participation from domestic institutional investors as well as retail investors. Tarsons Products stock price has shown a correction from its post-IPO peak during FY 2024-25. Tarsons Products earnings announcements have acted as key factors influencing trading activity across both exchanges.

Tarsons Products Limited Stock Performance And Share Price History

Tarsons Products share price showed strong movement after its IPO listing in FY 2021-22, followed by a correction phase in later periods. Over the three-year period from FY 2022-23 to FY 2024-25, Tarsons Products stock price has recorded a negative qualitative compound annual growth rate (CAGR). This trend has been influenced by margin compression due to higher raw material costs and lower capacity utilisation after expansion.

Tarsons Products share price history during FY 2024-25 indicates a continued decline from earlier peak levels. Earnings performance during this period remained below initial expectations set during the IPO phase. As a result, Tarsons Products investor sentiment has shifted from positive at the time of listing to more cautious.

Tarsons Products volatility has remained noticeable, which is consistent with its small-cap classification. Tarsons Products share trend has also been influenced by spending patterns in pharmaceutical and diagnostic sectors, which directly affect demand for laboratory consumables.

Tarsons Products Limited Investor Relevance And Role In Portfolio

Tarsons Products investment case has been linked to India’s import substitution opportunity in laboratory consumables and the growth of domestic pharmaceutical research and diagnostic services. Tarsons Products share price indicates that investors are evaluating the company’s earnings performance in relation to expectations set during its IPO.

Tarsons Products fundamentals show the impact of increased depreciation related to capacity expansion at its Amta plant during FY 2024-25. The Price-to-Earnings ratio, or Tarsons Products P/E ratio, has remained relatively high compared to current earnings levels. Earnings Per Share, or Tarsons Products EPS, has shown a declining trend during the same period.

Tarsons Products live price continues to be tracked by investors interested in the laboratory consumables segment. The company remains relevant for those focusing on domestic manufacturing in the scientific equipment space and the role of import substitution in India’s laboratory ecosystem.

Tarsons Products Limited Sectoral Relevance And Peer Positioning

Tarsons Products operates in the laboratory consumables and scientific instruments manufacturing segment. Tarsons Products peer comparison includes companies such as Borosil Limited, Thermo Fisher Scientific India, Merck Life Science, HiMedia Laboratories, and Hindustan Latex Limited. These companies serve similar institutional customers and provide laboratory-related products.

Tarsons Products market cap has declined from its post-IPO levels during FY 2024-25, reflecting the gap between earlier expectations and actual earnings performance. Tarsons Products SWOT analysis indicates that the company’s domestic manufacturing base and wide product range differentiate it within the sector.

Tarsons Products is positioned within India’s laboratory supply chain as a manufacturer with a focus on plastic labware. Its role differs from multinational companies that primarily focus on distribution. The company is associated with the domestic production of laboratory consumables used across research and healthcare institutions.

Conclusion

Tarsons Products Limited is a manufacturer of plastic laboratory consumables and reusable labware serving research, pharmaceutical, diagnostic, and academic institutions. The company operates within India’s life sciences and scientific instruments sector with manufacturing facilities in West Bengal and a presence in domestic and export markets. Tarsons Products share price reflects its listing on BSE and NSE and its sensitivity to sectoral demand and earnings performance. While its stock performance has seen a correction after initial post-IPO momentum, the company remains relevant in the context of domestic labware manufacturing and import substitution within India’s laboratory ecosystem.